%20(5).png)
Empowering Diabetic Health with Intelligent Robotics
Nannil Intelligent Robotics Co., Ltd. is transforming how the world manages diabetes. We design and develop cutting-edge robotic and AI-powered solutions that support early detection, enhance preventive care, and improve patients' quality of life.
Whether at home or in a clinic, our technology empowers healthcare providers and patients with tools that are precise, easy to use, and clinically effective.
-
Over 530 million people worldwide live with diabetes
-
More than 50% are at risk of developing peripheral neuropathy
-
Current monofilament testing methods are manual, inconsistent, and lack digital records
-
Huge opportunity in primary care, telehealth, and home-use diagnostics
.png)
Smart Robotic Monofilament Tester for Diabetic Neuropathy
Empower Your Diabetic Care
Smart and Accessible Technology
Elevate your diabetic care with our innovative health tech solution that provides AI-driven technology for early detection and better outcomes
AUTOMATED MONOFILAMENT SCREENING DEVICE
Revolutionizes peripheral neuropathy screening by making it standardized, affordable, and easy to use— without requiring a specialist
PORTABLE DESIGN, DIGITAL DATA RECORDING, AND AI-SUPPORTED CONSISTENCY
It brings diagnostic precision directly to the patients who need it most — even in rural or underserved areas.
Diabtics
Automated monofilament device
An automated monofilament device for screening diabetic peripheral neuropathy
Motor-controlled pressure
Features motor-controlled pressure with AI-based precision
Instant digital results
Provides instant digital results and historical tracking
Mobile app and cloud platform
Connects to mobile app and cloud platform for physician review
User-friendly
User-friendly for both clinics and home environments
Smart Robotic Monofilament Tester for Diabetic Neuropathy
Award-Winning Diabetic Screening Device Wins Gold at International Invention Expo — Poised to Transform Global Diabetes Care , Geneva, Switzerland
We are thrilled to announce that our Diabetic Neuropathy Screening Device (Diabtics: Smart Robotic Monofilament Tester for Diabetic Neuropathy) has been honored with the Gold Medal with the Congratulations of the Jury at the prestigious 50th International Exhibition of Inventions Geneva, held from April 9–13, 2025 at Palexpo, Switzerland. This recognition not only validates the cutting-edge innovation behind our technology but also reinforces its global impact and market readiness.
Transforming Diabetes Management
Experience the Future of Diabetes Care with Diabtics
%20(1).png)
Subscribe Your Order
Contact
Nannil Intelligent Robotics Co., Ltd
Center for Biomedical and Robotics Technology (BART LAB),
Faculty of Engineering, Mahidol University
999 Phutthamonthon Sai 4 Rd, Salaya, Nakhon Pathom 73170
+66-84-332-0033